Aspira Research and Development Expense Trend from 2010 to 2022

AWH
 Stock
  

USD 0.97  0.10  9.35%   

Aspira Womans Research and Development Expense is decreasing over the last several years with stable swings. Research and Development Expense is estimated to finish at about 5.7 M this year. During the period from 2010 to 2022 Aspira Womans Health Research and Development Expense regressed destribution of quarterly values had coefficient of variationof 59.56 and r-squared of  0.026746. Aspira Womans Interest Expense is most likely to decrease significantly in the upcoming years. The last year's value of Interest Expense was reported at 48,000. The current Research and Development Expense is estimated to increase to about 5.7 M, while Consolidated Income is projected to decrease to (32.5 M).
  
Check Aspira Womans financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira main balance sheet or income statement drivers, such as Direct Expenses of 4 M, Cost of Revenue of 3.2 M or Gross Profit of 3.3 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0925, PPandE Turnover of 14.04 or Receivables Turnover of 10.21. Aspira financial statements analysis is a perfect complement when working with Aspira Womans Valuation or Volatility modules. It can also supplement Aspira Womans' financial leverage analysis and stock options assessment as well as various Aspira Womans Technical models . Please continue to the analysis of Aspira Womans Correlation against competitors.

Aspira Womans Quarterly Research and Development Expense

1.35 Million

Aspira Research and Development Expense Breakdown

Showing smoothed Research and Development Expense of Aspira Womans Health with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.Aspira Womans' Research and Development Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womans' overall financial position and show how it may be relating to other accounts over time.
Research and Development Expense10 Years Trend
Decreasing
Stable
   Research and Development Expense   
Share
       Timeline  

Aspira Research and Development Expense Regression Statistics

Arithmetic Mean 3,210,117
Geometric Mean 2,547,810
Coefficient Of Variation 59.56
Mean Deviation 1,689,050
Median 2,595,000
Standard Deviation 1,911,974
Range 5,183,526
R-Value(0.16)
R-Squared 0.026746
Significance 0.59
Slope(80,290)

Aspira Research and Development Expense History

20122.2 M
20132.6 M
20144.7 M
20153.8 M
20162.2 M
2017837 K
2018550 K
2019M
20202.1 M
20215.3 M
20225.7 M

About Aspira Womans Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Aspira Womans income statement, its balance sheet, and the statement of cash flows. Aspira Womans investors use historical funamental indicators, such as Aspira Womans's Research and Development Expense, to determine how well the company is positioned to perform in the future. Although Aspira Womans investors may use each financial statement separately, they are all related. The changes in Aspira Womans's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aspira Womans's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aspira Womans Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aspira Womans. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Research and Development Expense5.3 M5.7 M
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Aspira Womans Investors Sentiment

The influence of Aspira Womans' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Aspira. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Aspira Womans' public news can be used to forecast risks associated with investment in Aspira. The trend in average sentiment can be used to explain how an investor holding Aspira can time the market purely based on public headlines and social activities around Aspira Womans Health. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Aspira Womans' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Aspira Womans' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Aspira Womans' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Aspira Womans.

Aspira Womans Implied Volatility

    
  401.23  
Aspira Womans' implied volatility exposes the market's sentiment of Aspira Womans Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Aspira Womans' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Aspira Womans stock will not fluctuate a lot when Aspira Womans' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aspira Womans in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aspira Womans' short interest history, or implied volatility extrapolated from Aspira Womans options trading.

Pair Trading with Aspira Womans

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womans position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womans will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aspira Womans

0.82AXDXAccelerate Diagnosti Earnings Call  This WeekPairCorr

Moving against Aspira Womans

0.7ABVCAbvc Biopharma Earnings Call  TomorrowPairCorr
0.65ACHVAchieve Life Sciences Earnings Call  TomorrowPairCorr
0.62ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
0.6BIOCBiocept Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to Aspira Womans could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womans when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womans - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womans Health to buy it.
The correlation of Aspira Womans is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womans moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womans Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womans can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Aspira Womans Correlation against competitors. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
120.1 M
Quarterly Revenue Growth YOY
0.27
Return On Assets
-0.48
Return On Equity
-0.95
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.